Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.50 |
| ▸ | RAB9A | P51151 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | ATP4A | P20648 | 4/20 | 0.43 |
| ▸ | ATP4B | P51164 | 4/20 | 0.43 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CASP3 | P42574 | 1/20 | 0.42 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.42 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.42 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.41 |
| ▸ | UBE2T | Q9NPD8 | 1/20 | 0.41 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15722747 | 1.00 | NPC1 (0.50) | NPC1RAB9AALDH1A1GAAATP4A | |
| SCHEMBL23185863 | 1.00 | NPC1 (0.50) | NPC1RAB9AALDH1A1GAAATP4A | |
| SCHEMBL15722637 | 1.00 | NPC1 (0.50) | NPC1RAB9AALDH1A1GAAATP4A | |
| SCHEMBL18369556 | 0.99 | NPC1 (0.51) | NPC1RAB9AALDH1A1GAAATP4A | |
| SCHEMBL15722636 | 0.94 | NPC1 (0.52) | NPC1RAB9AALDH1A1GAAATP4A | |
| SCHEMBL16851750 | 0.88 | NPC1 (0.48) | NPC1RAB9AALDH1A1GAAATP4A | |
| SCHEMBL21675553 | 0.86 | ILK (0.43) | NPC1RAB9AALDH1A1GAASMN1; SMN2 | |
| SCHEMBL21413246 | 0.86 | ILK (0.43) | NPC1RAB9AALDH1A1GAASMN1; SMN2 | |
| SCHEMBL21675451 | 0.86 | ILK (0.43) | NPC1RAB9AALDH1A1GAASMN1; SMN2 | |
| SCHEMBL21233554 | 0.86 | ILK (0.43) | NPC1RAB9AALDH1A1GAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10968189-B2 | Method for producing 2-hydrazinobenzothiazole derivative | DIC CORPORATION (JP) | 2021-04-06 | — | — | US | disclosed |
| US-10927087-B2 | Method for producing polymerizable compound | DIC CORPORATION (JP) | 2021-02-23 | — | — | US | disclosed |
| US-20200165215-A1 | METHOD FOR PRODUCING 2-HYDRAZINOBENZOTHIAZOLE DERIVATIVE | DIC CORPORATION (JP) | 2020-05-28 | — | — | US | disclosed |
| US-20190322872-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICAL FILM, OPTICALLY ANISOTROPIC BODY, POLARIZER, FLAT PANEL DISPLAY, ORGANIC ELECTROLUMINESCENCE DISPLAY, ANTIREFLECTION FILM, AND COMPOUND | ZEON CORPORATION (JP) | 2019-10-24 | — | — | US | disclosed |
| US-9643942-B2 | Method for manufacturing 1,1-disubstituted hydrazine compound | ZEON CORPORATION (JP) | 2017-05-09 | — | — | US | disclosed |
| US-9643942-B2 | Method for manufacturing 1,1-disubstituted hydrazine compound | ZEON CORPORATION (JP) | 2017-05-09 | — | — | US | disclosed |
| US-9586917-B2 | Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound | ZEON CORPORATION (JP) | 2017-03-07 | — | — | US | disclosed |
| US-9586917-B2 | Polymerizable compound, polymerizable composition, polymer, optically anisotropic body, and method for producing polymerizable compound | ZEON CORPORATION (JP) | 2017-03-07 | — | — | US | disclosed |
| US-20170008862-A1 | METHOD FOR MANUFACTURING 1,1-DISUBSTITUTED HYDRAZINE COMPOUND | ZEON CORPORATION (JP) | 2017-01-12 | — | — | US | disclosed |
| US-20170008862-A1 | METHOD FOR MANUFACTURING 1,1-DISUBSTITUTED HYDRAZINE COMPOUND | ZEON CORPORATION (JP) | 2017-01-12 | — | — | US | disclosed |
| US-20160280672-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | ZEON CORPORATION (JP) | 2016-09-29 | — | — | US | disclosed |
| US-20160280672-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | ZEON CORPORATION (JP) | 2016-09-29 | — | — | US | disclosed |
| US-20150175564-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | ZEON CORPORATION (JP) | 2015-06-25 | — | — | US | disclosed |
| US-20150175564-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | ZEON CORPORATION (JP) | 2015-06-25 | — | — | US | disclosed |
| EP-2871192-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | Zeon Corporation (JP) | 2015-05-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190322872-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICAL FILM, OPTICALLY ANISOTROPIC BODY, POLARIZER, FLAT PANEL DISPLAY, ORGANIC ELECTROLUMINESCENCE DISPLAY, ANTIREFLECTION FILM, AND COMPOUND | H1-0, H1-4, H1-10 | NPC1 3463/4885RAB9A 3060/4885ALDH1A1 379/4885 |
| US-20170008862-A1 | METHOD FOR MANUFACTURING 1,1-DISUBSTITUTED HYDRAZINE COMPOUND | HRH1, HBZ, H1-0 | NPC1 2157/4885RAB9A 603/4885ALDH1A1 209/4885 |
| US-20200165215-A1 | METHOD FOR PRODUCING 2-HYDRAZINOBENZOTHIAZOLE DERIVATIVE | HAO2, IDH2, HACL2 | NPC1 2261/4885RAB9A 3845/4885ALDH1A1 159/4885 |
| US-20160280672-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | PYM1, C5, C1S | NPC1 3672/4885RAB9A 3942/4885ALDH1A1 987/4885 |
| US-10927087-B2 | Method for producing polymerizable compound | INCENP, INF2, INHA | NPC1 4131/4885RAB9A 3222/4885ALDH1A1 693/4885 |
| US-20150175564-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC BODY, AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | PYM1, C5, C1S | NPC1 3672/4885RAB9A 3942/4885ALDH1A1 987/4885 |
| US-10968189-B2 | Method for producing 2-hydrazinobenzothiazole derivative | HAO2, IDH2, HACL2 | NPC1 2261/4885RAB9A 3845/4885ALDH1A1 159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.